Which stocks have an unusual volume on Friday?
By Mill Chart
Last update: Mar 8, 2024
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.
Unusual volume stocks
| Ticker | Change | Comment |
|---|---|---|
| APM | 18.51% | APTORUM GROUP LTD-CLASS A (NASDAQ:APM) has an unusual volume of 6.22M shares today. NASDAQ:APM is advancing 18.51% today. The average volume over the last 50 days is 1.72M, making today's volume 261.0% above the average. This signifies a notable change in market participation. |
| NKGN | 27.46% | NKGEN BIOTECH INC's (NASDAQ:NKGN) traded a high volume of 5.06M shares. Shares in NASDAQ:NKGN are on the rise, with a gain of 27.46% observed in today's trading session. The average daily volume over 50 days is 2.5M, so this is 102.0% above the average volume. |
| QNRX | 4.28% | With 2.21M shares traded so far, QUOIN PHARMACEUTICALS LT-ADR (NASDAQ:QNRX) is experiencing an unusual level of activity today. Investors in NASDAQ:QNRX are enjoying a price surge of 4.28% today, indicating bullish market sentiment. The average volume over the last 50 days is 636.56K, making today's volume 246.0% above the average. This signifies a notable change in market participation. |
| CELZ | 6.19% | The trading activity for CREATIVE MEDICAL TECHNOLOGY (NASDAQ:CELZ) has surged with a volume of 482.89K shares today. Shares are rising by 6.19%. The average daily volume over 50 days is 235.71K, so this is 105.0% above the average volume. |
| GROM | -7.81% | GROM SOCIAL ENTERPRISES INC (NASDAQ:GROM) has an unusual volume of 938.05K shares today. Shares are falling by 7.81%. Today's trading volume is 22.7% above the average 50-day volume, indicating a significant deviation from the norm. Yesterday the company had a press release: Grom Social Enterprises, Inc. to Further Expand Entertainment Offerings Through Gaming as it Enters Into Letter of Intent to Acquire Leading Gaming Company, Arctic7. |
| AIMD | 88.37% | The trading volume of AINOS INC (NASDAQ:AIMD) today is 50.02M shares, which is considered unusual. Investors in NASDAQ:AIMD are enjoying a price surge of 88.37% today, indicating bullish market sentiment. Compared to the average daily volume of the past 50 days, the current volume is 4.0K% above, suggesting an unusual level of trading activity. |
| IPA | 2.17% | So far 2.18M shares of IMMUNOPRECISE ANTIBODIES LTD (NASDAQ:IPA) have traded in today's session. The market is favoring NASDAQ:IPA today, as its share price records a notable increase of 2.17%. This is 252.0% above the average daily volume of the last 50 days. A press release (IPA’s subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM Stacking and HYFT Technology) was released yesterday. |
| PIK | -3.92% | KIDPIK CORP's (NASDAQ:PIK) traded a high volume of 886.09K shares. This decline in share price leads to a decrease of 3.92%. The average daily volume over 50 days is 349.67K, so this is 153.0% above the average volume. |
| MBIO | -5.76% | 348.09K shares of MUSTANG BIO INC (NASDAQ:MBIO) have been traded so far today. Leading to a price decrease of 5.76%. The average volume measured over 50 days is 123.93K, so this is 181.0% above the average volume. |
| YGMZ | -5.77% | The trading activity for MINGZHU LOGISTICS HOLDINGS L (NASDAQ:YGMZ) has surged with a volume of 380.08K shares today. Leading to a price decrease of 5.77%. The average daily volume over 50 days is 273.58K, so this is 38.93% above the average volume. |
Our unusual volume stocks screener will show you the full list.
MUSTANG BIO INC
NASDAQ:MBIO (5/10/2024, 4:02:46 PM)
0.26
-0.01 (-3.77%)
MBIO News
Potential Additional Gross Proceeds Upon Cash Exercise of Warrants of Up to $12 Million...
WORCESTER, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical...
11 days ago - ChartmillWhat's going on in today's sessionMonday's session: top gainers and losers
a month ago - InvestorPlace3 Biotech Stocks to Turn $5,000 Into $1 Million: April 2024Biotech stocks can offer some of the most explosive, exciting opportunities on the market.That is, if you find the right one.
Planning for proof-of concept Phase 1 investigator-sponsored clinical trial evaluating MB-106 CD20-targeted CAR T-cell therapy in autoimmune diseases is...
WORCESTER, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for difficult-to-treat cancers and rare genetic diseases, today announced financial results and recent corporate highlights for the full-year ended December 31, 2023.
2 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayWe're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!
2 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayPre-market stock movers are worth checking out on Thursday to get an idea of the hottest stocks worth watching this morning!
MB-101 was well-tolerated and 50% of patients achieved stable disease or better with two partial responses and two complete responses lasting 7.5 and 66+...
WORCESTER, Mass., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical...
5 months ago - Seeking AlphaMustang Bio files to sell 2.74M shares of common stock for holders (NASDAQ:MBIO)Mustang Bio files prospectus for resale of 2.74 million common shares; this document is not an offer to sell these securities.
Data showed favorable safety profile, complete response rate and durability in the treatment of patients with relapsed or refractory indolent B-cell...
